Msn Laboratories Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SUNITINIB MALATE, with a corresponding US DMF Number 33308.
Remarkably, this DMF maintains an Active status since its submission on November 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 15, 2019, and payment made on May 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II